Relevium Launches LeefyLyfe™ Organic Hemp Products in the US
November 20 2019 - 9:18AM
Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB:“RLLVF” and
Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to
announce the launch of LeefyLyfeTM Organics, a comprehensive line
of organic health and wellness products formulated with broad
spectrum organically sourced Scandinavian hemp.
Organically Sourced Broad-Spectrum
ExtractsThe carefully crafted premium line of organic hemp
extracts are sourced from slow-grown hemp and extracted with CO2
and formulated with MCT oil and rich flavonoids to enhance overall
well-being. Each formulated LeefyLyfeTM product contains the purest
unprocessed form of hemp extracts with all the beneficial qualities
present in hemp.
A Complete Line of Premium Organic
HempThe Company has launched a 1000Mg Organic Hemp Oil
Drops with Citrus flavonoids and a 1000Mg Organic Hemp Gummy Bears
with Wild Berry flavonoids, both part of an initial series of eight
(8) products planned to be released over the next six months. The
two products were officially launched yesterday and are available
for purchase on Amazon.com and will be available on all the
company’s online platforms in the coming weeks.
Aurelio Useche, CEO of Relevium Technologies
stated: “We are delighted to officially launch LeefyLyfeTM Organic
Hemp, our premium line of carefully crafted broad spectrum hemp
products. Over the next several months we plan to add a unique
series of newly formulated products sourced from non-GMO organic
hemp from Scandinavia and carefully blended in the US”.
Neither the TSX Venture Exchange nor its
Regulation Services Provider (as that term is defined in policies
of the TSX Venture Exchange) accepts responsibility for the
adequacy or accuracy of this release.
About Relevium
TechnologiesRelevium is a publicly traded company that
operates in the health and wellness industry, including legal
cannabis, with a primary focus on online distribution. The
principal business of the Company is the identification,
evaluation, acquisition and operation of brands and businesses in
the health and wellness markets and medical cannabis. The Company
pursues its business strategy through an acquisition and
partnership model in a holistic approach to encompass a wide range
of health and wellness consumer products. Relevium operates through
two wholly owned subsidiaries:
BGX E-Health LLC (BGX), based in Orlando,
Florida, markets dietary supplements, nutraceuticals, sports
nutrition and cosmeceuticals primarily through its Bioganix® brand
portfolio in the US and Europe. Relevium’s premium brands are sold
at some of the world’s largest retailers including Walmart.com and
Amazon.com.
Biocannabix Health Corporation (BCX), based in
Montreal, Quebec, is a biopharma nutraceutical company focused on
delivering pediatric endo-medicinal nutraceuticals for cannabinoid
therapy.
Cautionary Note Regarding
Forward-Looking StatementsThis release includes certain
statements and information that may constitute forward-looking
information within the meaning of applicable Canadian and United
States securities laws. All statements in this news release, other
than statements of historical facts, including statements regarding
future estimates, plans, objectives, assumptions or expectations of
future performance, are forward-looking statements and contain
forward-looking information. Generally, forward- looking statements
and information can be identified using forward-looking terminology
such as "intends" or "anticipates", or variations of such words and
phrases or statements that certain actions, events or results
"may", "could", "should", or "would" occur. Forward-looking
statements are based on certain material assumptions and analysis
made by the Company and the opinions and estimates of management as
of the date of this press release. These forward-looking statements
are subject to known and unknown risks, uncertainties and other
factors that may cause the actual results, level of activity,
performance or achievements of the Company to be materially
different from those expressed or implied by such forward-looking
statements or forward-looking information.
Although management of the Company has attempted
to identify important factors that could cause actual results to
differ materially from those contained in forward-looking
statements or forward-looking information, there may be other
factors that cause results not to be as anticipated, estimated or
intended. There can be no assurance that such statements will prove
to be accurate, as actual results and future events could differ
materially from those anticipated in such statements. Accordingly,
readers should not place undue reliance on forward- looking
statements and forward-looking information. Readers are cautioned
that reliance on such information may not be appropriate for other
purposes. The Company does not undertake to update any
forward-looking statement, forward-looking information or financial
outlook that are incorporated by reference herein, except in
accordance with applicable securities laws. We seek to rely on the
applicable safe harbor.
On Behalf of the Board of Directors
RELEVIUM TECHNOLOGIES
INC.Aurelio UsechePresident and CEO
For more information about this press
release:
Tel: +1.888.528.8687
RELEVIUM TECHNOLOGIES INCEmail:
investors@releviumcorp.comWebsite: www.releviumtechnologies.com
Relevium Technologies (TSXV:RLV)
Historical Stock Chart
From Jun 2024 to Jul 2024
Relevium Technologies (TSXV:RLV)
Historical Stock Chart
From Jul 2023 to Jul 2024